Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Archer Aviation Inc (ACHR) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Archer Aviation IncTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Archer Aviation Inc vs Neurocrine Biosciences Inc — how do they compare? Archer Aviation Inc trades at $6.93 (market cap $5.23B), while Neurocrine Biosciences Inc trades at $152.5 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.1× Archer Aviation Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Archer Aviation Inc nearer its low. Which is the better fit depends on your goals.

ACHRNBIX
Market Cap
$5.23B$16.46B
Sector
IndustrialsHealth
52-Week High
$13.64$185.50
52-Week Low
$4.44$123.10
Enterprise Value
$3.79B$16.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Archer Aviation Inc

Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.

Read more on ACHR

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX